HSD130 Utilization and Factors Associated with the Use of Alternative Pembrolizumab Dosing Regimens in Real-World: A US-Based EMR Study
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1130
https://www.valueinhealthjournal.com/article/S1098-3015(22)01331-6/fulltext
Title :
HSD130 Utilization and Factors Associated with the Use of Alternative Pembrolizumab Dosing Regimens in Real-World: A US-Based EMR Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01331-6&doi=10.1016/j.jval.2022.04.1130
First page :
Section Title :
Open access? :
No
Section Order :
11008